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Abstract 
A cDNA encoding M2-type pymvate kinase from mouse was cloned and its nucleotide sequence was determined. The cDNA encoded 
a protein containing 531 antino acids, the nucleotide and amino acid sequences of which were 93.2% and 98.1%, respectively, 
homologous to those of rat M2 pyruvate kinase. Expression of the pyruvate kinase in mouse mbryonal carcinoma PI9 cells altered 
according to differentiation stages; high at undifferentiated and low at differentiated stages. 
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Pyruvate kinase (PK) is known to be a key enzyme in 
the glycolytic pathway, and its enzymological properties 
have been extensively studied. Four isozymes, M1, M2, L 
and R types of PK were reported in mammalian cells 
[1-3], and these are expressed in different issues and cells 
of different developmental stages. The M2 type PK (M2- 
PK) is considered to be a prototype, and is expressed in 
early fetal tissues as well as in most of the adult tissues 
[4,5]. The cDNAs of rat [6] and human [7] for the M2-PK 
were cloned. In this paper, we describe the isolation of the 
mouse M2-PK cDNA and its expression patterns during 
differentiation of mouse embryonal carcinoma (EC) P19 
cells. 
We first isolated the DNA fragment whose gene(s) are 
expressed preferentially in undiffrentiated mouse EC cells 
P19 or F9. Total cDNAs were extracted from a cDNA 
library prepared from undifferentiated F9 cells (kindly 
supplied by Dr. Keiko Ozato, National Institute of Health, 
Bethesda, USA), and used as templates for polymerase 
chain reaction (PCR). A PCR product obtained with primers 
of oligo-dT and Box (5'-TAATAGCAAACCAGGATTGT- 
~ The nucleotide sequence data reported in this paper will appear in the 
DDBJ/EMBL/GSDB/NCBI database under the accession number 
D38379. 
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TCTCGTTC-3'), a regulatory element related to EC differ- 
entiation [8], contained 410 base pairs and were named 
Box-F1. Northern blot analysis with a Box-F1 probe in the 
course of differentiation i  vitro of F9 or P19 cells re- 
vealed that the gene containing Box-F1 was preferentially 
expressed in the cells at undifferentiated stages (data not 
shown). We then screened the AZAP cDNA library from 
mouse undiffrentiated PCC4 cells (Stratagene, USA) using 
Box-Fl as a probe. Among 4. |0  4 plaques screened, 32 
positive clones were isolated, which were of two groups 
containing the inserts of approximately 2.25 kb or 2.1 kb. 
Since the 2.1 kb insert carried the same sequences as the 
2.25 kb one but lacked the 3'-terminal region, we further 
analyzed the clone of the longer 2.25 kb insert. 
The 2.25 kb insert in AZAP was subcloned into 
pBluscriptSK- by infection of helper phage to the AZAP 
clone as described in the manuals from Stratagene Inc. The 
nucleotide sequence of the insert was determined by 
dideoxy termination method after construction of several 
deletion mutants from 5'-end (Fig. 1). Homology search in 
data bases revealed that the clone we isolated was a mouse 
homologue of the rat M2-type pyruvate kinase (PK) cDNA. 
Total nucleotide number of the cDNA for mouse M2-PK 
was 2146 and possessed the open reading frame encoding 
531 amino acids. The homology of nucleotide sequences 
between mouse and rat was 93.2%. Nucleotide substitu- 
tions were distributed over the entire sequence of the 
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mPK-M2 
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1 *********************************************************************** - - *****  
TGcG•AGC•C•GCA•AGcAGCGACCCGT•CTAAGTCGACAGACGTCCTCTTTAGGTATTGCAACAGGAT*T*********  
12 CCGAGC~CTTCAGG~C~'~CG~CCACAC~'I~GC~GGG~ETGCCTTCA'PI~AG~CCAGCAGCTCCATGCAGC 
~*t~*~t~~*~*~*~*~G~t~*~t~t*~t* t~*~*~*~*~*~**~*t t******** t***~ 
92 CATGGCTGA•A•CTTCCTGGAAC•CATGTGcCGc•TGGACATTGACTCTGCCCCCATCACGGCC•GCAACACTGGCATCA 
172 TTTGTACCATTGGGCCTGCTTCCCGATCTGTGGAGATGCTGAAGGAGATGATTAAGT•TGGAATGAATGTGGCTCGGCTG 
252 AAT TTCTC TCATGGAACCC ATGAG TACCATGCAGAGACCATCAAGAATG TCC GTGAAGCCACAGAA~C TTTGCATCTGA 
332 TCC CATTC TC TAC CGTCC TGTTGCGGTGGCTCTGGATACAAAGGGAC*  TGAGATCCGGACTGGAC TCATCAAGGGCAGC G
412 GCACcGCTGAGGTGGAGcTGAAGAAGGGAGC~ACTcTGAAGAT~ACCCTGGACAACGCTTACATGG~AAGTGTGACGAG 
492 AACATCCTGCGGTTGGACTACAAGAACATCTGCAAGGTGGTGGAGGTGGGCAGCAAGATCTACGTGGACGATGGG•TCAT 
********************************************************************************  
572 CTC AC TGCAGGTGAAGGAGAAAG GCGC TGACTTCCTGG TGACGGAGGTGGAGAATGGTGGCTC C TTGGGCAGC AAGAAGG 
********************************•*********•**•*****•****************************  
652 GCG TGAAC C TGCC GGGCGC TGC TGTGGATCTCCCCGC TGTGTC GGAAAAGGACATCCAGGACC TGAAG TTTGG CGTGG AG 
********************************************************************************  
732 CAGGATGTGG~ATGGTG TTTGCATCTT TCATC CGCAAGGCAGCCGAC G TGCATGAAG TC~GAAGGTGC TGGGAGAGAA 
********************************************************************************  
812 GGGCAAGAACATCAAGATCATCAGCAAAATCGAGAACC~TGAAGGCGTCCGCAGGTTTGATGAGATCTTGGAGGcC)~CG 
********************************************************************************  
892 ATGGGATCATGGTGGCTCGTGGTGACCTGGGCA•TGAGATTCCTGCAGAGAAGGTCTTCCTGTCTCAGAAGATGATGATC 
********************************************************************************  
972 GGGCGATGCAACCGAGCTGGGAAGCCTGTCATCTGTTCCACACAGATGCTGGAGATCATGATCAAGAAGCCACGCC•CAc  
********************************************************************************  
1052 CCG TGCTGAAGGCAG TGATG TGG CCAATGCAGTCCTGG ATGGAGCAGACTGCATCATGC TGTC TGGAGAAACAGCCAAGG 
********************************************************************************  
1132 GGGAcTACCCTCTGGAGGCTGTTCGCATGcAGCACCTGATTGCCCGAGAGGCAGAGGCTGCCATCTACCACTTGCAGCTA 
********************************************************************************  
1212 TTCGAGGAACTCCGCCGCCTGGCGCCCATTAC•AGCGA•CC•AC•GAAGCTGcCGCCGTGGGTGCCGTGGAGGCCTCCTT 
1292 •AAGTGCTGCAGTGGGG••ATTATCGTG•TCAC•AAGTCTGGCAGGAGTG•TCACCAAGTGG•CAGGTACCGCCCTCGGG 
1372 CTC CTATC ATTGCCGTGACTCGAAATCCCCAGACTGCTCGCCAGGCCCATCTG TACCG TGGCATCTTCCCTGTGCTGTGT 
********************************************************************************  
1452 AAGGATGCCGTGCTGAATGCCTGGGCTGAGGATGTCGACCTTCGTGTAAACTTGGCCATGGATGTTGGCAAGGcCCGAGG 
********************************************************************************  
1532 CTTCTTCAAGAAGGGAGATGTGGTCATTGTGCTGACCGGGTGGCGCCCTGGCTCTGGATTCACCAACACcATGCGTGTAG 
********************************************************************************  
1612 TGCCTGTACC%~r~J iTGGCcCTCTGGAGCCCCTCTTCTAGCCCCTGTCCCTTCCCCTCCCCTATCCTTTCCATTAGGCCAG 
********************************************************************************  
1692 CAACGCTTGT~TGCTCAC TCTGGGCCATAGTG TGGCGCTGGTGGGCTGGGACACCAGGGAAAATTAATGCCTCTAAAAC 
*****_**************************************************************************  
1772 ATGCAATAGAGACCAGCTATTATTCAGGGCCCTACCTGAGCCAGGGGTGGAGGAGGAATGCAGGACTGGAAACC- -CTGA 
*****************************__**************************************************  
1850 CTT TATCACAGAAGGGCGGCAGCATCTC-  -TGGACTTTGCTTC TGT~GAAAGTTGT-CAGAGAATTCGCAGCCCTAGCCT 
********************************************************************************  
1927 GGAGTCAGGAGACAGCAAGAGTAGGGGCTGAGGTTGTGGGGCCCAGGGTCCCAGTGTAGATGACGAcTTCTGGCCCTGGC 
*****************************  . . . . . . .  * ***********************___****************  
2007 CCTGACCTGCTTTCCCAACAGCTTTGGCcTCCCCACTCCTTGTGCACTCCACTTCTGTCACTGCAGACACTCCACTCTcC 
****************************** - - _***********************************************  
2087 ACC TTGTATTCTGCA- -GTC TCCAGGCC TGTTGC TATAGTGCC CACCTGAATG TCAATAAAG . . . . . . . . . . . . . . . . . .  
* *********************************************************************__  
AAAAAAKAAAAAAAAAAA 
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mPK -142 
rPK-142 
rPK-MI  
hPK -142 
i MPKPHSEAGTAF I QTQQLHAAMADTFLEHMCRLD I DSAP I TARNTGI  i CT  
e~eeD~eeee~eeeee~e~eeee~eooeeeeee~e~ee,e~eeeee~ 
eSeoe~ee~eeee, .eeeeeeeeeee~eeeeeee~e~pe~ee~eee~ 
51 I GPAS RSVEMLKEMI  KS~ARLNFSHGTHEYHAET I  KNVREATES FAS 
eeeeee~eee~eee~*ee~.eeee~eo~ee~eee,e~eeeeeAeeeeeee  
- . . . . - . . .T . . . . . . . . . . . . . . . . - - . . . - - . . . . . - . - .T . . . . . . .  
101 DP ILYRPVAVALDTKGPEIRTGL IKGSGTAEVELKKGATLK ITLDNAYME 
151 KCDENILRLDYKNICKVVEVGSKIYVDDGLISLQVKEKGADFLVTEVENG 
oeoeeeeWaelee le le ,eee le l Jee Jeeoeee leee ,oeyoeeoeeaa  
ooee leaWeleee leoogo , ,oem.eeee ,eeoeee loe Jeyeeeoeeee  
aoe loeeWoe looeoe Je Io°eoeeee leo leeo i I~eeoee Io .eoeee  
201 GSLGSKKGVNLPGAAVDLPAVSEKD I QDLKFGVEQD~AS F I RKAAD 
251 VHEVRKVLGEKGKNI  K I I SK I ENIIEGVRRFDE ILEASDGIMVARGDLGTE 
301 I PAE KVFLSQKI~II GRCNRAGKPVI  C STQMLE IMI KKPRPTRAEGSDVAN 
- . . - - ' - 'A ' ' ' ' ' ' - ' ' ' ' ' ' ' - ' 'A - ' ' ' ' S ' ' - ' - ' ' . . . . - - . - . .  
. . . . . . . .  A . . . . . . . . . . . . . . . . .  A ..... S . . . . . . . . . . . . . . . . .  
. . . . . ' ' -A ' ' ' ' ' ' ' ' - ' ' ' ' ' ' ' 'A ' ' ' ' ' S ' - ' ' ' ' . . . . . . . . . . .  
351 AVLDGADC IMLS GETAKGDYPLEAVRMQHL I AREAEAAI  YHLQLFEELRR 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  VF .RL  . . . . .  A .  
401  LAP I TS DPTEAAAVGAVEAS FKCCSGAI  IVLTKSGRSAHQVARYRPRAP I 
ASSQST" "L" "M'M'S .... Y. • LAA'L  .... E . . . . . . . . . . . . . . . . .  
451 IAVTRNPQTARQAHLY RG I FPVLCKDAVLNAWAE DVDLRVNLAMDVGKAR 
' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' 'D ' ' ' ' ' ' ' ' ' ' ' ' ' 'N - . . . .  
~eeeeee ,eee , ,o~.~eoeeee~,e~eD~e~ee~l ,eeeeNe~eo~ 
. . . . . . . . . . . . . . . . . . . . . . . . . .  P .QE  . . . . . . . . . . .  F" .N . . . . .  
501 GFFK KGDVV I VLTGWRPGSGFTNTMRWPVP 
Fig. 2. Comparison of amino acid sequences among MI- and M2-type pyruvate kinase of various species. The amino acid sequence predicted ~om the 
cDNA of the mouse M2-PK (mPK-M2) is shown in the uppermost lines. Amino acids a~ shown in the standa~ single letter abbreviations. Dots indicate 
the identical amino acids in the PKs of the rat M2 type (rPK-M2), the rat MI type (rPK-M1) and the human M2 type (hPK-M2). 
mouse M2-PK  as compared  to that of the rat M2-PK.  The 
amino acid sequence predicl:ed for the mouse M2-PK  was 
98.1%, 94.2%, and 96.6% homologous  to the rat M2 type 
[6], rat M1 type [6], and the human M2 type [7] PKs, 
respect ively (Fig. 2). 
Express ion of  the mouse M2-PK  gene was invest igated 
by Northern blot hybr id izat ion in terms of the differentia- 
t ion of  the cells. Mouse  EC P19 cells were cultured in 
Du lbecco 's  modi f ied Eagle 's  MEM supplemented with 
10% fetal calf  serum. The cells were induced to differenti-  
Fig. 1. Nucleotide sequence of the cDNA for the mouse M2 type pyruvate kinase and comparison with the sequence of the rat counterpart. Nucleotide 
sequences of the M2-PK cDNAs from mouse (mPK-M2) and rat (rPK-M2) [6] are shown. Stars indicate the identical sequences between the two, and bars 
show missing nucleotides. ATG initiation and TGA stop codons in the mPK-M2 are marked by squares. 
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but not other types, was expressed in the early fetus, and 
that the expression was progressively replaced in various 
tissues by the other types of PK during development [4,5]. 
In immunoblot  analyses of hepatoma cells, the expression 
of M2-PK was correlated with its differentiation stages 
[10]. These results consistently suggest that the M2 type 
PK is preferentially expressed in undifferentiated cells and 
the expression decreases during the progression of differ- 
entiation. 
Probe mPK-M2 G3PDH 
Fig. 3. Expression of M2 type PK gene during differentiation i mouse 
P19 cells. Mouse embryonal carcinoma PI9 cells were induced to differ- 
entiate in vitro by the addition of retinoic acid, and total RNAs were 
extracted from the cells at 0, 2 and 4 days after induction. The RNA was 
blotted to a nitrocellulose filter and hybridized with 3z P-labelled cDNA 
probe of the mouse M2-PK (mPK-M2) or the human G3PDH. Positions 
of 18S and 28S ribosomal RNAs are indicated. 
ate in vitro by the addition of 1 /xM retinoic acid to the 
culture medium immediately after replating on a 10 cm 
dish at a density of 2 .10  5 cells, as described previously 
[8]. Total RNA was extracted at various time after induc- 
tion by the guanidine-isothiocyanate method [9], and 20 
/xg of the RNA were blotted to a nitrocellulose filter. The 
entire mouse M2-PK cDNA or the human cDNA for 
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) were 
labelled and used as probes for hybridization under highly 
stringent conditions. As described previously [8], P I9  cells 
differentiated almost completely at day 4 of induction. The 
results of Northern blotting showed the M2-PK gene dra- 
matically decreased uring induction of differentiation, as 
compared to the expression of G3PDH (Fig. 3). A previous 
report on the rat M2-PK gene showed that only the M2-PK, 
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